About this compound
Tirzepatide is a 39-residue synthetic peptide with dual affinity for the GIP and GLP-1 receptors, acylated with a C20 fatty diacid for albumin binding.
Studied in
- Incretin-receptor signalling
- Glucose handling
- Metabolic models
Compound identity
| Compound | Tirzepatide |
|---|---|
| CAS number | 2023788-19-2 |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4,813.53 Da |
Specifications
- Purity method: HPLC
- Appearance: Lyophilized powder
- Solubility: Reconstitute per protocol; see Supplies for diluents.
- We don't publish a purity percentage here — that figure is only meaningful tied to the lot you actually receive, so it lives on the lot certificate.
Metabolic
Tirzepatide
A dual GIP and GLP-1 receptor agonist.
What the research targets
Studied in gut-hormone (GIP and GLP-1) receptor signalling models.
Research use only
Supplied to qualified professionals and institutions for laboratory research. Not a drug, supplement or cosmetic, and not for human or veterinary use. We publish no dosing or administration guidance of any kind.
Supply formats
Buy one, or a case of ten.
Available as a vial or a Stick.
Single unit
One unit.
10 mgVial
SK-8259105-10-MG
On verified account15 mgVial
SK-8259105-15-MG
On verified account30 mgVial
SK-8259105-30-MG
On verified account60 mgVial
SK-8259105-60-MG
On verified accountSkinni Stick™ 40 mgSkinni Stick™New
Single-compound Skinni Stick™. Supplied to verified accounts only.
SK-8259105-PEN-40-MG
On verified account
Case — 10-pack
10 of the same size, at the 10-pack price.
Case · 10 × 10 mg
10-pack price — 10 × one unit, per vial.
SK-8259105-C10-10-MG
On verified accountCase · 10 × 15 mg
10-pack price — 10 × one unit, per vial.
SK-8259105-C10-15-MG
On verified accountCase · 10 × 30 mg
10-pack price — 10 × one unit, per vial.
SK-8259105-C10-30-MG
On verified accountCase · 10 × 60 mg
10-pack price — 10 × one unit, per vial.
SK-8259105-C10-60-MG
On verified accountCase · 10 × Skinni Stick™ 40 mgNew
10-pack price — 10 × one unit, per vial.
SK-8259105-C10-PEN-40-MG
On verified account
One-time verification of professional or institutional affiliation. No payment is taken on this site.
Compared with another compound
Where a study examined Tirzepatide and another catalog compound in the same participants, the comparison page reports that trial — its population, its duration and its endpoint. Where no such study exists, it says so rather than comparing results across separate trials.
From the research library
All articlesCited summaries of the published work behind Tirzepatide — what was studied, in which model, and what was measured.
Supplies
Third-party testing of research peptides: what the literature shows
Identity, purity and impurity profiling of synthetic peptides, a published study of vials bought online, and what a lot certificate can and cannot show.
Metabolic
Incretin receptors: one, two, or three
GLP-1, GIP and glucagon receptors, and what the single-, double- and triple-agonist trials set out to measure.